Examining reporting and representation of patients with cancer in COVID-19 clinical trials.
Maya RabowChristine WangHala T BornoPeggy Mary TahirEric J SmallHala T BornoPublished in: Cancer reports (Hoboken, N.J.) (2021)
This study observed that cancer history was not uniformly collected or reported among published COVID-19 therapeutic studies. Among reported publications, we observed that patients with a cancer diagnosis were generally overrepresented. However, patients with a cancer diagnosis were notably underrepresented in outpatient COVID-19 therapeutic studies.